We had a great week in Melbourne from 18–21 August 2026, where we participated in the International Diabetes Federation Western Pacific Region Congress (IDF-WPR) 2026, held in conjunction with the Australasian Diabetes Congress (ADC) and Metabolic Diseases 2026 at the Melbourne Convention and Exhibition Centre, Australia.
The congress brought together healthcare professionals, researchers and industry experts from around the world and Australasia to explore the latest developments in diabetes research, clinical care, education and community priorities.
Photo credits: SG Diagnostics
Showcasing the STRIDE Framework
We are pleased to presented under Stream 4: Epidemiology, Public Health and Policy, showcasing how the STRIDE1 framework empowers smarter and more effective chronic disease management through decentralised point-of-care HbA1c screening.
What does STRIDE stands for1:
S – Screening
T – Tailored Approach
R – Risk Reduction
I – Innovation
D – Data-Driven E – Empowerment
The framework combines accessible point-of-care testing with digital risk stratification to help identify at-risk individuals earlier and address gaps in traditional healthcare delivery. By bringing testing closer to patients, healthcare providers can gain timely health insights, enable more targeted interventions and follow-up, and support more connected patient care.
Medibus by Diabetes Alliance Program Plus (DAP+)
Moving Towards More Accessible Diabetes Care with the University of Newcastle
We are proud to share our collaboration journey with University of Newcastle and PolygenRx in support of the Diabetes Alliance Program Plus (DAP+), an established programme of diabetes care that aims to improve the prevention, detection, treatment and self-management of diabetes in rural and regional communities in Australia.
This collaboration reflects our shared commitment to improving health outcomes and supporting more connected diabetes care. By integrating accessible point-of-care testing solutions into community-based care, we aim to help overcome barriers to diabetes screening and bring testing closer to those who need it.
Together, we look forward to exploring how innovative solutions can improve access to diabetes screening and support effective disease management across different healthcare settings.
